Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R-2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study | AVESİS

Ankara Üniversitesi Akademik Veri Yönetim Sistemi

Quality of Life Was Not Negatively Impacted By the Addition of Lenalidomide to R-CHOP Chemotherapy (R-2-CHOP) Compared with Placebo Plus R-CHOP Chemotherapy in Patients with Previously Untreated Activated B-Cell (ABC)-Type Diffuse Large B-Cell Lymphoma (DLBCL): Health-Related Quality of Life (HRQoL) Analysis of the International Robust Study

Atıf İçin Kopyala

Chiappella A., Witzig T. E., Cocks K., Greenwood M., Williams A., Scott D. W., ...Daha Fazla

61st Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 7 - 10 Aralık 2019, cilt.134

Yayın Türü: Bildiri / Özet Bildiri
Cilt numarası: 134
Doi Numarası: 10.1182/blood-2019-123948
Basıldığı Şehir: Florida
Basıldığı Ülke: Amerika Birleşik Devletleri
Ankara Üniversitesi Adresli: Evet